Company intelligence / Profile preview
Mediolanum Farmaceutici
Milan, Lombardy, Italymediolanum-farma.it ↗
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
01
Overview
Mediolanum Farmaceutici S.p.A. is an Italian pharmaceutical group founded in Milan in 1972. The company focuses on research and development of innovative drugs with a strong presence in Italy and growing international reach. Its core business covers cardiovascular/metabolic diseases as well as expanding activities in oncology and rare diseases. The group has developed four original pharmaceutical products to date and holds over 700 patents across more than forty countries. Recent clinical-stage assets include immunotherapies for cancer and rare immune disorders—bolstered by the acquisition of French biotech ElsaLys Biotech—and small molecules for inflammatory eye disease. Its R&D pipeline currently comprises at least four active projects spanning from preclinical to Phase II trials.
- Therapeutic areas
- OncologyPulmonologyEndocrinologyImmunologyRheumatologyCardiovascularOphthalmology
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)Immunotherapeutic vaccinesHumanized Fab fragmentsBiologics
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Apeptico GmbH for solnatide projectPanoptes Pharma for PP–001 uveitis programActicor BioTherapeutics for ACT–017 stroke therapy
Beyond the preview
Go deeper on Mediolanum Farmaceutici.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mediolanum Farmaceutici.